Release Date: 04/03/09 11:13 Summary: Expansion of Contingent Resources - Gazonor Price Sensitive: Yes Download Document 94.51KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%